Dennis Argentieri
Papers
1
Total Citations
12
H-Index
1
About
Dennis Argentieri is a researcher whose work bridges pharmacology and high-throughput screening technologies, with a particular focus on lipid signaling pathways. His most cited contribution, "Robotic assay of sphingomyelinase activity for high throughput screening" (2000, 12 citations), exemplifies his expertise in developing automated, scalable methods for studying sphingomyelinase—an enzyme critical to sphingolipid metabolism and implicated in diseases like atherosclerosis and neurodegeneration. By integrating robotics with biochemical assays, Argentieri enabled the rapid, reproducible measurement of enzyme activity, a foundational step for drug discovery efforts targeting sphingomyelinase-related disorders. This work reflects his broader interest in translational assay design, where precision and efficiency are paramount. While his citation count may be modest, the technical rigor of his approach has informed subsequent high-throughput screening protocols in lipid enzymology. Argentieri’s contributions are particularly valuable for researchers seeking to automate complex biochemical measurements, demonstrating how method development can accelerate therapeutic target validation. His career underscores the importance of cross-disciplinary innovation—combining robotics, biochemistry, and pharmacology—to address challenges in early-stage drug development.
Research Focus
Key Achievements
Top Papers
- 1